Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...
The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people with Parkinson’s disease, according to a new study. Researchers ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
The Washington Post on MSN6d
She was diagnosed with Parkinson’s at 27. These were her warning signs.People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
The Manual on MSN13h
How do brain chemicals affect your ability to stick to your fitness resolutions?Scientists point to a lack of certain brain chemicals as a key player when it comes to sticking to those fitness resolutions ...
In December 2003, Osbourne was involved in an accident while riding his four-wheel all-terrain vehicle at his English estate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback